1. Acute Stroke: Delays to Presentation and Emergency Department Evaluation
2. Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke
3. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
4. Kaste M, Hacke W: Desmoteplase in acute ischemic stroke (DIAS) Phase II Study Results (abstract). American Stroke Association 29th International Stroke Conference, San Diego, Calif., 2004.
5. Warach S, Davis L: ReoPro Retavase reperfusion of stroke safety study imaging evaluation (ROSIE): Open-label, dose escalation, safety and proof of principle study of the combination of intravenous abciximab and reteplase in the treatment of acute ischemic stroke with proven perfusion defects. Ongoing Clinical Trials Session (abstract). The American Stroke Association 28th International Stroke Conference, Phoenix, Ariz., 2003.